Business UpdateJun 9, 2026, 07:11 AM
Zeo ScientifiX Expands Medical Advisory Board with Nine New Members
AI Summary
Zeo ScientifiX, Inc. announced the expansion of its Medical Advisory Board with the addition of nine highly-recognized physicians and scientific innovators. This move strengthens the company's scientific leadership across key disciplines in regenerative and longevity medicine, including orthopedics, oncology, and pain management. The expanded board will focus on advancing scientific rigor, clinical standards, and physician education as access to regenerative medicine grows in the United States.
Key Highlights
- Zeo ScientifiX expanded its Medical Advisory Board with nine new physicians and scientific innovators.
- New members specialize in regenerative and longevity medicine, orthopedics, oncology, pain management, and plastic surgery.
- The expanded board aims to advance scientific rigor, clinical standards, and physician education in regenerative medicine.
- The board will provide strategic guidance on scientific development, clinical protocols, and educational initiatives.
- New advisors include Andrea Asseff-Llanes, Elizabeth Parrish, Faryal Farooqi, Michael Swartzon, Mark A. Rosenberg, Constantino Mendieta, Neel Amin, David Karli, and Jacob Sanchez.
- The company was named a semi-finalist for the $101 million XPRIZE Healthspan longevity prize competition.
- The company emphasizes building science first and ensuring biologic offerings meet high clinical integrity standards.
Price Impact
More from ZEOX